(Q43939202)

28 November 2017

0 references

TIE2-expressing monocytes: a novel cellular biomarker for hepatocellular carcinoma? (English)

1 reference

28 November 2017

0 references

Michele De Palma

1

1 reference

28 November 2017

George Coukos

series ordinal

2

1 reference

28 November 2017

David Semela

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

6 March 2013

1 reference

28 November 2017

1 reference

28 November 2017

volume

57

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

1294-1296

1 reference

28 November 2017

cites work

Hepatocellular carcinoma

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.

21 January 2018

1 reference

High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.

21 January 2018

1 reference

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

Angiogenesis in liver disease

21 January 2018

1 reference

Angiogenesis and hepatocellular carcinoma

21 January 2018

1 reference

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

21 January 2018

1 reference

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C.

21 January 2018

1 reference

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

21 January 2018

1 reference

Significance of circulating endothelial progenitor cells in hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors

1 reference

7 January 2021

The parallel lives of angiogenesis and immunosuppression: cancer and other tales

1 reference

7 January 2021

Expression of Tie-2 by human monocytes and their responses to angiopoietin-2

1 reference

7 January 2021

An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood

1 reference

7 January 2021

Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26025

1 reference

28 November 2017

1 reference